Population ‐based study examining the utilization of preventive medicines by older people in the last year of life
ConclusionsThe present explorative study highlighted that some PM, such as statins, continue to be prescribed until death, particularly those that might have been beneficial earlier in life, but have an uncertain or unfavorable risk–benefit ratio towards the end‐of‐life. Geriatr Gerontol Int 2018; ••: ••–••
Source: Geriatrics and Gerontology International - Category: Geriatrics Authors: Sujita W Narayan, Prasad S Nishtala Tags: Original Article: Epidemiology, Clinical Practice and Health Source Type: research
More News: Aspirin | Cancer | Cancer & Oncology | Cholesterol | Clopidogrel | Coumadin | Epidemiology | Geriatrics | Plavix | Pradaxa | Statin Therapy | Study | Warfarin | Women